Search
Leader | 00000nz a2200037n 45 0 | ||
---|---|---|---|
001 | WKP|Q90118771 (VIAF cluster) (Authority/Source Record) | ||
003 | WKP | ||
005 | 20241121000210.0 | ||
008 | 241121nneanz||abbn n and d | ||
035 | ‡a (WKP)Q90118771 | ||
024 | ‡a 0000-0003-0447-3107 ‡2 orcid | ||
035 | ‡a (OCoLC)Q90118771 | ||
100 | 0 | ‡a Yang Wang ‡c researcher (ORCID 0000-0003-0447-3107) ‡9 en | |
670 | ‡a Author's A Network Pharmacology Analysis to Explore the Effect of on Traumatic Brain Injury | ||
670 | ‡a Author's Author Correction: Directed self-assembly of herbal small molecules into sustained release hydrogels for treating neural inflammation | ||
670 | ‡a Author's Chaihu-Shugan-San Reinforces CYP3A4 Expression via Pregnane X Receptor in Depressive Treatment of Liver-Qi Stagnation Syndrome | ||
670 | ‡a Author's Deciphering the Therapeutic Mechanisms of Wuzi Ershen Decoction in Treating Oligoasthenozoospermia through the Network Pharmacology Approach | ||
670 | ‡a Author's Development of a sensitive and rapid UHPLC-MS/MS method for simultaneous quantification of nine compounds in rat plasma and application in a comparative pharmacokinetic study after oral administration of Xuefu Zhuyu Decoction and nimodipine | ||
670 | ‡a Author's Directed self-assembly of herbal small molecules into sustained release hydrogels for treating neural inflammation | ||
670 | ‡a Author's Exploring Pharmacological Mechanisms of Xuefu Zhuyu Decoction in the Treatment of Traumatic Brain Injury via a Network Pharmacology Approach | ||
670 | ‡a Author's Gancao | ||
670 | ‡a Author's Gancao (Glycyrrhizae Radix) provides the main contribution to Shaoyao-Gancao decoction on enhancements of CYP3A4 and MDR1 expression via pregnane X receptor pathway in vitro | ||
670 | ‡a Author's iTRAQ-Based Proteomics Analysis Reveals the Effect of Rhubarb in Rats with Ischemic Stroke | ||
670 | ‡a Author's Metabolomics analysis of the hippocampus in a rat model of traumatic brain injury during the acute phase | ||
670 | ‡a Author's Plasma and cerebrospinal fluid pharmacokinetics of hydroxysafflor yellow A in patients with traumatic brain injury after intravenous administration of Xuebijing using LC-MS/MS method | ||
670 | ‡a Author's Quantitative proteomic analysis of intracerebral hemorrhage in rats with a focus on brain energy metabolism | ||
670 | ‡a Author's Rhein Suppresses Neuroinflammation via Multiple Signaling Pathways in LPS-Stimulated BV2 Microglia Cells | ||
670 | ‡a Author's VISSA-PLS-DA-Based Metabolomics Reveals a Multitargeted Mechanism of Traditional Chinese Medicine for Traumatic Brain Injury | ||
909 | ‡a (orcid) 0000000304473107 ‡9 1 | ||
919 | ‡a networkpharmacologyanalysistoexploretheeffectofontraumaticbraininjury ‡A A Network Pharmacology Analysis to Explore the Effect of on Traumatic Brain Injury ‡9 1 | ||
919 | ‡a authorcorrectiondirectedselfassemblyofherbalsmallmoleculesintosustainedreleasehydrogelsfortreatingneuralinflammation ‡A Author Correction: Directed self-assembly of herbal small molecules into sustained release hydrogels for treating neural inflammation ‡9 1 | ||
919 | ‡a chaihushugan3reinforcescyp3a4expressionviapregnane10receptorindepressivetreatmentofliverqistagnationsyndrome ‡A Chaihu-Shugan-San Reinforces CYP3A4 Expression via Pregnane X Receptor in Depressive Treatment of Liver-Qi Stagnation Syndrome ‡9 1 | ||
919 | ‡a decipheringthetherapeuticmechanismsofwuziershendecoctionintreatingoligoasthenozoospermiathroughthenetworkpharmacologyapproach ‡A Deciphering the Therapeutic Mechanisms of Wuzi Ershen Decoction in Treating Oligoasthenozoospermia through the Network Pharmacology Approach ‡9 1 | ||
919 | ‡a developmentofasensitiveandrapiduhplcmsmsmethodforsimultaneousquantificationof9compoundsinratplasmaandapplicationinacomparativepharmacokineticstudyafteroraladministrationofxuefuzhuyudecoctionandnimodipine ‡A Development of a sensitive and rapid UHPLC-MS/MS method for simultaneous quantification of nine compounds in rat plasma and application in a comparative pharmacokinetic study after oral administration of Xuefu Zhuyu Decoction and nimodipine ‡9 1 | ||
919 | ‡a directedselfassemblyofherbalsmallmoleculesintosustainedreleasehydrogelsfortreatingneuralinflammation ‡A Directed self-assembly of herbal small molecules into sustained release hydrogels for treating neural inflammation ‡9 1 | ||
919 | ‡a exploringpharmacologicalmechanismsofxuefuzhuyudecoctioninthetreatmentoftraumaticbraininjuryviaanetworkpharmacologyapproach ‡A Exploring Pharmacological Mechanisms of Xuefu Zhuyu Decoction in the Treatment of Traumatic Brain Injury via a Network Pharmacology Approach ‡9 1 | ||
919 | ‡a gancao ‡A Gancao ‡9 1 | ||
919 | ‡a gancaoglycyrrhizaeradixprovidesthemaincontributiontoshaoyaogancaodecoctiononenhancementsofcyp3a4andmdr1expressionviapregnane10receptorpathwayinvitro ‡A Gancao (Glycyrrhizae Radix) provides the main contribution to Shaoyao-Gancao decoction on enhancements of CYP3A4 and MDR1 expression via pregnane X receptor pathway in vitro ‡9 1 | ||
919 | ‡a itraqbasedproteomicsanalysisrevealstheeffectofrhubarbinratswithischemicstroke ‡A iTRAQ-Based Proteomics Analysis Reveals the Effect of Rhubarb in Rats with Ischemic Stroke ‡9 1 | ||
919 | ‡a metabolomicsanalysisofthehippocampusinaratmodeloftraumaticbraininjuryduringtheacutephase ‡A Metabolomics analysis of the hippocampus in a rat model of traumatic brain injury during the acute phase ‡9 1 | ||
919 | ‡a plasmaandcerebrospinalfluidpharmacokineticsofhydroxysaffloryellowainpatientswithtraumaticbraininjuryafterintravenousadministrationofxuebijingusinglcmsmsmethod ‡A Plasma and cerebrospinal fluid pharmacokinetics of hydroxysafflor yellow A in patients with traumatic brain injury after intravenous administration of Xuebijing using LC-MS/MS method ‡9 1 | ||
919 | ‡a quantitativeproteomicanalysisofintracerebralhemorrhageinratswithafocusonbrainenergymetabolism ‡A Quantitative proteomic analysis of intracerebral hemorrhage in rats with a focus on brain energy metabolism ‡9 1 | ||
919 | ‡a rheinsuppressesneuroinflammationviamultiplesignalingpathwaysinlpsstimulatedbv2microgliacells ‡A Rhein Suppresses Neuroinflammation via Multiple Signaling Pathways in LPS-Stimulated BV2 Microglia Cells ‡9 1 | ||
919 | ‡a vissaplsdabasedmetabolomicsrevealsamultitargetedmechanismoftraditionalchinesemedicinefortraumaticbraininjury ‡A VISSA-PLS-DA-Based Metabolomics Reveals a Multitargeted Mechanism of Traditional Chinese Medicine for Traumatic Brain Injury ‡9 1 | ||
996 | ‡2 LC|nr 93005593 | ||
996 | ‡2 ISNI|0000000374399424 | ||
996 | ‡2 RERO|A000175164 | ||
996 | ‡2 ISNI|0000000048690419 | ||
996 | ‡2 LC|no 96004549 | ||
996 | ‡2 NTA|128419490 | ||
996 | ‡2 DNB|1293281883 | ||
996 | ‡2 SUDOC|197649793 | ||
996 | ‡2 SUDOC|200242334 | ||
996 | ‡2 ISNI|0000000039936261 | ||
996 | ‡2 RERO|A000175168 | ||
996 | ‡2 PLWABN|9810699370505606 | ||
996 | ‡2 LC|n 89119931 | ||
996 | ‡2 ISNI|0000000382154013 | ||
996 | ‡2 CYT|AC000618006 | ||
996 | ‡2 CYT|AC000259077 | ||
996 | ‡2 NKC|jo2012712442 | ||
996 | ‡2 PLWABN|9811769723105606 | ||
996 | ‡2 ISNI|0000000064086465 | ||
996 | ‡2 PLWABN|9810700645405606 | ||
996 | ‡2 ISNI|0000000419504938 | ||
996 | ‡2 LC|nr 91006479 | ||
996 | ‡2 DNB|119901432X | ||
996 | ‡2 PLWABN|9811772643705606 | ||
996 | ‡2 RERO|A022471671 | ||
996 | ‡2 ISNI|0000000044596636 | ||
996 | ‡2 LC|no2013117926 | ||
996 | ‡2 ISNI|0000000382078620 | ||
996 | ‡2 DNB|1082352861 | ||
996 | ‡2 ISNI|0000000050263803 | ||
996 | ‡2 KRNLK|KAC200305298 | ||
996 | ‡2 ISNI|0000000383147085 | ||
996 | ‡2 DNB|1325550272 | ||
996 | ‡2 DNB|1263239447 | ||
996 | ‡2 DNB|1306927129 | ||
996 | ‡2 CYT|AC000208961 | ||
996 | ‡2 ISNI|0000000067817681 | ||
996 | ‡2 SUDOC|122895169 | ||
996 | ‡2 LC|n 79125295 | ||
996 | ‡2 LC|nr2003019226 | ||
996 | ‡2 ISNI|0000000118724769 | ||
996 | ‡2 DNB|1191854175 | ||
996 | ‡2 CYT|AC000259585 | ||
996 | ‡2 CYT|AC000259584 | ||
996 | ‡2 NII|DA11188595 | ||
996 | ‡2 LC|n 91122821 | ||
996 | ‡2 ISNI|0000000063803979 | ||
996 | ‡2 DNB|115862848X | ||
996 | ‡2 LC|n 2017053987 | ||
996 | ‡2 LC|n 80165857 | ||
996 | ‡2 PLWABN|9810590626205606 | ||
996 | ‡2 LC|n 2010004711 | ||
996 | ‡2 DNB|127129839 | ||
996 | ‡2 LC|n 96061111 | ||
996 | ‡2 BNF|15537696 | ||
996 | ‡2 W2Z|1707991624519 | ||
996 | ‡2 LC|n 2019022257 | ||
996 | ‡2 CAOONL|ncf11701070 | ||
996 | ‡2 CYT|AC000653455 | ||
996 | ‡2 NUKAT|n 2016064576 | ||
996 | ‡2 LC|no2007107351 | ||
996 | ‡2 DNB|1319275516 | ||
996 | ‡2 ISNI|0000000110882201 | ||
996 | ‡2 ISNI|0000000072688335 | ||
996 | ‡2 CYT|AC000653596 | ||
996 | ‡2 DNB|1246367033 | ||
996 | ‡2 BNF|13741722 | ||
996 | ‡2 LC|no2023033414 | ||
996 | ‡2 ISNI|0000000493981273 | ||
996 | ‡2 CYT|AC000639427 | ||
996 | ‡2 DNB|1216422443 | ||
996 | ‡2 DNB|1295769077 | ||
996 | ‡2 DNB|119040123 | ||
996 | ‡2 ISNI|0000000051248656 | ||
996 | ‡2 DNB|136032141 | ||
996 | ‡2 ISNI|0000000381607893 | ||
996 | ‡2 ISNI|0000000381719764 | ||
996 | ‡2 NDL|00891034 | ||
996 | ‡2 NTA|181979667 | ||
996 | ‡2 LC|no2007076514 | ||
996 | ‡2 CYT|AC000635108 | ||
996 | ‡2 LC|n 88218473 | ||
996 | ‡2 DNB|1345110839 | ||
996 | ‡2 SUDOC|176325719 | ||
996 | ‡2 DNB|1213268974 | ||
996 | ‡2 CYT|AC000208147 | ||
996 | ‡2 LC|n 87932263 | ||
996 | ‡2 DNB|105086039X | ||
996 | ‡2 DNB|1135745994 | ||
996 | ‡2 LC|n 88655967 | ||
996 | ‡2 LC|n 85275359 | ||
996 | ‡2 LC|nr 99008876 | ||
996 | ‡2 NSK|000708014 | ||
996 | ‡2 ISNI|0000000063591435 | ||
996 | ‡2 CYT|AC000633687 | ||
996 | ‡2 CYT|AC000642150 | ||
996 | ‡2 CAOONL|ncf11934366 | ||
996 | ‡2 BNF|17907041 | ||
996 | ‡2 LC|n 2019005326 | ||
996 | ‡2 LC|n 81077176 | ||
996 | ‡2 LC|n 2019051852 | ||
996 | ‡2 DNB|1075496675 | ||
996 | ‡2 DNB|1276866364 | ||
996 | ‡2 CYT|AC000642409 | ||
996 | ‡2 CYT|AC000259792 | ||
996 | ‡2 LC|no2021056836 | ||
996 | ‡2 DNB|1144302137 | ||
996 | ‡2 LC|nb2022013180 | ||
996 | ‡2 CYT|AC000636631 | ||
996 | ‡2 DNB|1226822312 | ||
996 | ‡2 ISNI|0000000083148027 | ||
996 | ‡2 CYT|AC000493487 | ||
996 | ‡2 NUKAT|n 2016006108 | ||
996 | ‡2 CYT|AC000046456 | ||
996 | ‡2 ISNI|0000000454529524 | ||
996 | ‡2 CYT|AC000615576 | ||
996 | ‡2 DNB|1190738546 | ||
996 | ‡2 DNB|101303029X | ||
996 | ‡2 ISNI|0000000481548931 | ||
996 | ‡2 BNF|15067230 | ||
996 | ‡2 ISNI|0000000382741402 | ||
996 | ‡2 DNB|1262029538 | ||
996 | ‡2 ISNI|0000000107188681 | ||
996 | ‡2 CYT|AC000400491 | ||
996 | ‡2 ISNI|0000000108178215 | ||
996 | ‡2 CYT|AC000400493 | ||
996 | ‡2 NTA|121186539 | ||
996 | ‡2 LC|nr 90011242 | ||
996 | ‡2 NTA|364168250 | ||
996 | ‡2 BNF|16264077 | ||
996 | ‡2 CYT|AC000652495 | ||
996 | ‡2 ISNI|0000000063553383 | ||
996 | ‡2 NKC|pna2006362718 | ||
996 | ‡2 DNB|1160063656 | ||
996 | ‡2 BIBSYS|1707991624519 | ||
996 | ‡2 CYT|AC000208847 | ||
996 | ‡2 LC|n 83047228 | ||
996 | ‡2 SUDOC|180575937 | ||
996 | ‡2 LC|no2018043014 | ||
996 | ‡2 DNB|1172300240 | ||
996 | ‡2 ISNI|0000000108452077 | ||
996 | ‡2 NSK|000461453 | ||
996 | ‡2 DNB|1274341760 | ||
996 | ‡2 PLWABN|9811566399305606 | ||
996 | ‡2 DNB|1104853744 | ||
996 | ‡2 RERO|A003957531 | ||
996 | ‡2 ISNI|0000000051083193 | ||
996 | ‡2 LC|no2009089152 | ||
996 | ‡2 CYT|AC000208926 | ||
996 | ‡2 ISNI|0000000054751003 | ||
996 | ‡2 ISNI|0000000053976251 | ||
996 | ‡2 BIBSYS|97052751 | ||
996 | ‡2 ISNI|0000000504765171 | ||
996 | ‡2 LC|no2021029733 | ||
996 | ‡2 DNB|1046472542 | ||
996 | ‡2 NTA|323258107 | ||
996 | ‡2 CYT|AC000210306 | ||
996 | ‡2 ISNI|0000000083347202 | ||
996 | ‡2 CYT|AC000659360 | ||
996 | ‡2 LNB|LNC10-000130656 | ||
996 | ‡2 LC|no2016100551 | ||
996 | ‡2 DNB|1237003016 | ||
996 | ‡2 LC|nr 98005496 | ||
996 | ‡2 ISNI|0000000063272194 | ||
996 | ‡2 DNB|1048031713 | ||
996 | ‡2 CYT|AC000000182 | ||
996 | ‡2 NKC|xx0243033 | ||
996 | ‡2 SUDOC|259894982 | ||
996 | ‡2 LC|n 2004054957 | ||
996 | ‡2 LC|no2022066439 | ||
996 | ‡2 DBC|87097969074782 | ||
996 | ‡2 ISNI|0000000383138330 | ||
996 | ‡2 CAOONL|ncf10382461 | ||
996 | ‡2 CAOONL|ncf10723261 | ||
996 | ‡2 LC|n 81106490 | ||
996 | ‡2 LC|n 83214563 | ||
996 | ‡2 ISNI|0000000073579034 | ||
996 | ‡2 ISNI|0000000444584167 | ||
996 | ‡2 LC|nr 90020957 | ||
996 | ‡2 DNB|1102201952 | ||
996 | ‡2 LIH|LNB:_g_E_q_;=B_t_ | ||
996 | ‡2 ISNI|0000000504288256 | ||
996 | ‡2 CYT|AC000451516 | ||
996 | ‡2 ISNI|0000000126262883 | ||
996 | ‡2 LC|no2023132808 | ||
996 | ‡2 DNB|1197420614 | ||
996 | ‡2 DNB|1072156938 | ||
996 | ‡2 BNF|16274233 | ||
996 | ‡2 NTA|369222458 | ||
996 | ‡2 CYT|AC000637335 | ||
996 | ‡2 J9U|987007370953405171 | ||
996 | ‡2 LC|no2015138325 | ||
996 | ‡2 DNB|1214393764 | ||
996 | ‡2 DNB|1231239352 | ||
996 | ‡2 PLWABN|9811771554805606 | ||
996 | ‡2 CYT|AC000641535 | ||
996 | ‡2 DNB|136338380 | ||
996 | ‡2 NTA|438699432 | ||
996 | ‡2 NDL|00346721 | ||
996 | ‡2 CYT|AC000272143 | ||
996 | ‡2 DNB|1059125005 | ||
996 | ‡2 DNB|123823609X | ||
996 | ‡2 DNB|1162524022 | ||
996 | ‡2 ISNI|0000000496169432 | ||
996 | ‡2 LC|n 2014077350 | ||
996 | ‡2 SZ|1259535304 | ||
996 | ‡2 SUDOC|250833409 | ||
996 | ‡2 LC|no2015086068 | ||
996 | ‡2 SUDOC|030260310 | ||
996 | ‡2 CYT|AC000259536 | ||
996 | ‡2 ISNI|0000000063389632 | ||
996 | ‡2 ISNI|0000000063126285 | ||
996 | ‡2 LC|nr 95005630 | ||
996 | ‡2 CYT|AC000540917 | ||
996 | ‡2 ISNI|0000000054852445 | ||
996 | ‡2 LC|n 83122292 | ||
996 | ‡2 RERO|A027169319 | ||
996 | ‡2 ISNI|0000000408834894 | ||
996 | ‡2 DNB|1338182404 | ||
996 | ‡2 NSK|000545635 | ||
996 | ‡2 BNF|15111569 | ||
996 | ‡2 LC|n 91026181 | ||
996 | ‡2 NTA|264440439 | ||
996 | ‡2 LC|n 2016181547 | ||
996 | ‡2 CAOONL|ncf10695737 | ||
996 | ‡2 SUDOC|176232397 | ||
996 | ‡2 LC|nr 98036737 | ||
996 | ‡2 DNB|1178378187 | ||
996 | ‡2 NUKAT|n 2021123640 | ||
996 | ‡2 DNB|1318496829 | ||
996 | ‡2 DNB|170718026 | ||
996 | ‡2 J9U|987007346074605171 | ||
996 | ‡2 LC|no2022106475 | ||
996 | ‡2 BIBSYS|8067012 | ||
996 | ‡2 SUDOC|189620226 | ||
996 | ‡2 LC|n 88031425 | ||
996 | ‡2 NSK|000705227 | ||
996 | ‡2 CYT|AC000208904 | ||
996 | ‡2 PLWABN|9810596153905606 | ||
996 | ‡2 BIBSYS|1470399606492 | ||
996 | ‡2 ISNI|0000000457685290 | ||
996 | ‡2 DNB|1315050080 | ||
996 | ‡2 LC|n 2013030029 | ||
996 | ‡2 CAOONL|ncf11934459 | ||
996 | ‡2 ISNI|0000000063799316 | ||
996 | ‡2 DNB|1187976628 | ||
996 | ‡2 CYT|AC000639520 | ||
996 | ‡2 LC|n 2010185031 | ||
996 | ‡2 CYT|AC000642354 | ||
996 | ‡2 DNB|1133094155 | ||
997 | ‡a 0 0 lived 0 0 ‡9 1 |